Insights Into 10x Genomics Inc (TXG) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

10x Genomics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Health Information Services industry. The current market capitalization of 10x Genomics Inc is $2.62B. A total of 1.62 million shares were traded on the day, compared to an average of 1.83M shares.

In the most recent transaction, McAnear Justin J. sold 2,936 shares of TXG for 24.30 per share on May 22 ’24. After the transaction, the Chief Financial Officer now owns 146,203 company shares. In a previous transaction on May 22 ’24, Saxonov Serge sold 4,877 shares at 24.30 per share. TXG shares that Chief Executive Officer owns now total 889,641.

Among the insiders who sold shares, Hindson Benjamin J. disposed of 4,087 shares on May 22 ’24 at a per-share price of $24.30. This resulted in the insider holding 350,055 shares of TXG after the transaction. In another insider transaction, Saxonov Serge sold 4,660 shares at $44.00 per share on Mar 04 ’24. Company shares held by the Chief Executive Officer now total 842,900.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TXG has a high of $57.90 and a low of $15.28.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.01, while its Total Shareholder’s Equity was $817.57M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 3.72.

Most Popular

Related Posts